Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide

The revised EMA guideline for the investigation of bioequivalence for immediate release oral formulations with systemic action

(2016) Roger K Verbeeck et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Determination of Bioequivalence for Drugs with Narrow Therapeutic Index: Reduction of the Regulatory Burden

(2016) Laszlo Endrenyi et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

Management of Patients With Atrial Fibrillation (Compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS Recommendations)

(2013) Jeffrey L. Anderson et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Safety of Flecainide

(2012) Juan Tamargo et al.   DRUG SAFETY

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

(2012) et al.   EUROPEAN HEART JOURNAL

CYP2D6 genotype affects age-related decline in flecainide clearance

(2012) Kosuke Doki et al.   Pharmacogenetics and Genomics

On the relationship between block of the cardiac Na+channel and drug-induced prolongation of the QRS complex

(2011) AR Harmer et al.   BRITISH JOURNAL OF PHARMACOLOGY

ACCF/AHA 2011 Health Policy Statement on Therapeutic Interchange and Substitution

(2011) et al.   CIRCULATION

The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events

(2011) H. Almroth et al.   JOURNAL OF INTERNAL MEDICINE

Usefulness of postmortem biochemistry in forensic pathology: Illustrative case reports

(2011) Cristian Palmiere et al.   Legal Medicine

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation

(2010) E. Aliot et al.   EUROPACE

Delirium in a Patient with Toxic Flecainide Plasma Concentrations: The Role of a Pharmacokinetic Drug Interaction with Paroxetine

(2009) Yvonne Y Tsao et al.   ANNALS OF PHARMACOTHERAPY

Comparing Generic and Innovator Drugs: A Review of 12 Years of Bioequivalence Data from the United States Food and Drug Administration

(2009) Barbara M Davit et al.   ANNALS OF PHARMACOTHERAPY

Life-Threatening Flecainide Intoxication in a Young Child Secondary to Medication Error

(2009) Lisa CA D'Alessandro et al.   ANNALS OF PHARMACOTHERAPY

Effects ofCYP2D6genotypes on age-related change of flecainide metabolism: involvement of CYP1A2-mediated metabolism

(2009) Kosuke Doki et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Generic drugs - safe, effective, and affordable

(2009) John R. Peters et al.   Dermatologic Therapy

Paranoid Psychosis and Myoclonus: Flecainide Toxicity in Renal Failure

(2008) Stephen Ting et al.   CARDIOLOGY

Therapie des paroxysmalen Vorhofflimmerns: Herzglykoside allein oder in Kombination mit Antiarrhythmika?*

(2008) G. Steinbeck et al.   DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

A randomized comparison of amiodarone and class IC antiarrhythmic drugs to treat atrial fibrillation in patients paced for sinus node disease: The Prevention Investigation and Treatment: A Group for Observation and Research on Atrial arrhythmias (PITAGORA) trial

(2007) Michele Gulizia et al.   AMERICAN HEART JOURNAL